Global HPV Testing Market 2016 Size, Trends, Share, Review, Demand, Growth upto 2022

Global HPV Testing Market 2015-2019

About HPV

HPV refers to a group of more than 200 related viruses commonly causing infections that do not have any symptoms. Global HPV testing market to grow at a CAGR of 16.17% over the period 2014-2019. Among these, more than 40 types of HPV cause highly contagious diseases that are transmitted through direct sexual contact, infecting both male and female genitals. The other types of HPV cause non-genital warts that are not sexually transmitted. Though most HPV infections are harmless and heal on their own, certain high-risk types of genital HPV can be persistent and cause cervical, penile, anal, vaginal, and oropharyngeal cancers. Many individuals undergo regular HPV tests as a preventive measure. HPV tests help detect the viral genetic material in a cell sample taken from the cervix.

Covered in this Report

This report covers the present and future scenarios of the global HPV testing market for the period 2015-2019. To calculate the market size, Technavio uses revenue generated from the sales of HPV testing kits and detection systems. The report includes the segmentation of the market based on the following three regions: the Americas, APAC, and EMEA.

Request For Sample Report : http://goo.gl/dzsOUI

Global HPV Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Our analyst researched the following companies as the key players in the global HPV testing market: Abbott Diagnostics, Hologic, Qiagen and Roche Diagnostics

Other Prominent Vendors in the market are: Arbor Vita, Becton, Dickinson and Company, Cepheid, Delphi Bioscience, DiaCarta, Diasorin, Fujirebio, Genera Biosystems, IncellDx, OralDNA Labs, Quest Diagnostics, Seegene, Trovagene and Ventana Medical Systems

Commenting on the report, an our analyst said: “HPV and Pap tests help detect cervical cancer in women. The Pap test identifies changes in cervical cells caused by HPV infection. The HPV test is used to check for HPV DNA in sample cells. A physician may advise a patient to undergo both HPV and Pap tests for the screening of cervical cancer. The American Cancer Society, the US Preventive Services Task Force, the American Society for Clinical Pathology, and the American Society for Colposcopy and Cervical Pathology have provided guidelines for the testing of cervical cancer in women in the US. These guidelines state that women aged between 30 and 65 should undergo Pap and HPV co-testing every five years or get a Pap test every three years.”

According to the report, HPV is the most widespread STD in both men and women. The infection can lead to cervical, vulvar, or vaginal cancer in women and penile cancer in men. In the US, about 20-million people are currently affected with HPV, and more than six-million individuals become infected each year. Research has revealed that HPV is commonly transmitted through unprotected sexual contact. Factors such as contact with infected skin, genital fluids, or lesions are responsible for the development of HPV infections. The low-risk infection does not lead to cancer, but it can cause condylomata acuminata on or around the genitals, anus, mouth, or throat. For instance, HPV types 6 and 11 account for 90% of genital warts. The high-risk infection, especially HPV types 16 and 18, is responsible for most HPV-related cancers.

Further, the report states that a lack of awareness of HPV and its diagnostic kits among people has a negative impact on market growth.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

About Us:

QY Market Research is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations.

Contact Us:

Joel John
Deerfield Beach, Florida 33442
United States
Toll Free: +1-855-465-4651 (USA-CANADA)
Tel: +1-386-310-3803
Web: QY Market Research
Email: sales@qymarketresearch.com

This release was published on openPR.